SCHEMBL8804101

SCHEMBL8804101

COC(=O)Oc1c(C)nc2c(c1-c1cccc(Cl)c1Cl)C(=O)CC(C)(C)C2

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
ALDH1A1 P00352 5/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP3A4 P08684 1/20 0.43
GSK3B P49841 1/20 0.41
CYP11B2 P19099 1/20 0.40
PTPN11 Q06124 8/20 0.39
OPRM1 P35372 1/20 0.39
MAPT P10636 3/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8802499 0.92 LMNA (0.44) LMNACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL7981878 0.84 LMNA (0.57) LMNACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL8802939 0.81 LMNA (0.47) LMNACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL8803102 0.80 TYK2 (0.38) PTPN11
SCHEMBL7977490 0.80 LMNA (0.55) LMNACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL10915061 0.74 PTPN11 (0.41) PTPN11
SCHEMBL8976107 0.70 ALDH1A1 (0.42) CYP1A2CYP2C9CYP2C19ALDH1A1PTPN11
SCHEMBL7979351 0.69 LMNA (0.80) LMNACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL7967452 0.67 CYP1A2 (0.55) LMNACYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL8802602 0.66 PTPN11 (0.36) PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0778769-A1 USE OF 5-SUBSTITUTED PYRIDINE AND HEXAHYDROQUINOLINE-3 CARBOXYLIC ACID DERIVATIVES FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM BAYER AG (DE) 1997-06-18 EP claimed
WO-1996006610-A1 USE OF 5-SUBSTITUTED PYRIDINE AND HEXAHYDROQUINOLINE-3 CARBOXYLIC ACID DERIVATIVES FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM BAYER AKTIENGESELLSCHAFT (DE) 1996-03-07 WO claimed